One page, thousands of outlets. See who else covered it.
Plus news about BioArctic, Enveda, Georgiamune, Kynexis, Tolerance Bio and Network Bio. Amgen puts the "can" in TScan: Amgen is terminating its partnership with TScan Therapeutics, the Waltham, MA-based T cell therapy maker said in ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Republicans are heavily scrutinizing the handling of the pandemic.
In a systematic review, researchers evaluated previously published studies of Lenke type 5 adolescent idiopathic scoliosis to examine the use of PCOs in combination with PSF and compare radiographic…
By Kwame Bediako Bayern Munich midfielder Jamal Musiala has disclosed that he was diagnosed with a neurological dysfunction following two collapses in pre-season friendlies.
"Long sleep duration is more uncommon at mid-life than short sleep duration," the study lead told Newsweek:
In the amylin race, drug design appears to be a key differentiator. Later this year, Novo Nordisk’s CagriSema is likely to become the first approved drug containing an amylin analog and a GLP-1…
An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the…
